Soon-Shiong’s NantHealth tanks on STAT report of self-dealing; Bioversys, Aptuit forge antibiotic collab; Helix gets new CEO
→ STAT reported that biotech billionaire Patrick Soon-Shiong used a $12 million “gift” to the University of Utah as a carefully disguised boost to his cancer business, steering $10 million of that back into his hands under a contract that has raised questions about the way the money was handled. And the report has taken a big bite out of the share price of NantHealth $NH, which dropped 23%.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.